1. Home
  2. GRDX vs WKHS Comparison

GRDX vs WKHS Comparison

Compare GRDX & WKHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GridAI Technologies Corp.

GRDX

GridAI Technologies Corp.

N/A

Current Price

$4.80

Market Cap

28.6M

Sector

Health Care

ML Signal

N/A

Logo Workhorse Group Inc.

WKHS

Workhorse Group Inc.

HOLD

Current Price

$2.92

Market Cap

31.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRDX
WKHS
Founded
N/A
2007
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
31.8M
IPO Year
2016
2008

Fundamental Metrics

Financial Performance
Metric
GRDX
WKHS
Price
$4.80
$2.92
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 86.9K
60.8K
Earning Date
11-18-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
21.95
★ 86.92
EPS
★ N/A
N/A
Revenue
N/A
★ $763,173.00
Revenue This Year
N/A
$61.80
Revenue Next Year
N/A
$67.74
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.87
$0.53
52 Week High
$6.93
$11.80

Technical Indicators

Market Signals
Indicator
GRDX
WKHS
Relative Strength Index (RSI) 65.13 45.24
Support Level $4.51 $2.81
Resistance Level $5.30 $3.56
Average True Range (ATR) 0.46 0.13
MACD 0.11 0.00
Stochastic Oscillator 81.16 36.03

Price Performance

Historical Comparison
GRDX
WKHS

About GRDX GridAI Technologies Corp.

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric vehicles, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

Share on Social Networks: